Effects of Replicative Senescence of Human Chorionic MSCs on Their EV-miRNA Profile

Overview

Journal Stem Cell Rev Rep

Publisher Springer

Specialty Cell Biology

Date 2024 Sep 21

PMID 39305404

Authors

Hedviga Kosuthova

Livia K Fecskeova

Jana Matejova

Lucia Slovinska

Marko Moravek

Zuzana Bartova

Denisa Harvanova

Affiliations

Soon will be listed here.

Abstract

Chorionic mesenchymal stromal cells (CHO-MSCs) and their extracellular vesicles (EVs) are becoming increasingly popular, since chorion is ethically harmless and an easily accessible source of MSCs. However, until now there is only a limited number of studies with a thorough characterization of CHO-MSCs derived EVs and their miRNA profile. In this study, we monitored changes in the EV-miRNA profile between early and late passage of human CHO-MSCs. First, senescence of CHO-MSCs was induced by serial passaging and confirmed by morphological changes, shortened telomeres and changes in the expression of selected genes. The expression of MSCs-specific surface markers CD73, CD90, CD105 did not change with increasing passages. Next, EVs and their miRNA profiles were compared between early vs late passage cells. Number of EVs and their size were not significantly changed. Seven of the top 10 most expressed EV-miRNAs were common to both early and late passages. A differential expression study between early and late passages identified 37 significantly differentially expressed EV-miRNAs, out of which 23 were found to be associated with pathways of cellular senescence based on KEGG pathway analysis. A set of 9 miRNAs were identified as the most frequently associated with senescence and/or with the most altered expression between early and late passages, out of which miR-145-5p, miR-335-5p and miR-199b-3p were the most significant downregulated miRNAs in late passages. The most upregulated EV-miRNAs were miR-1307-3p, miR-3615 and miR320b. Targeting these miRNAs in future experiments may prolong the therapeutic potential of CHO-MSCs and their EVs.

References

Potter M, Hill W, Isales C, Hamrick M, Fulzele S . MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells. Bone. 2020; 142:115679. PMC: 7901145. DOI: 10.1016/j.bone.2020.115679. View

Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D . PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 2016; 45(D1):D183-D189. PMC: 5210595. DOI: 10.1093/nar/gkw1138. View

Bertolo A, Baur M, Guerrero J, Potzel T, Stoyanov J . Autofluorescence is a Reliable in vitro Marker of Cellular Senescence in Human Mesenchymal Stromal Cells. Sci Rep. 2019; 9(1):2074. PMC: 6376004. DOI: 10.1038/s41598-019-38546-2. View

Jovic D, Yu Y, Wang D, Wang K, Li H, Xu F . A Brief Overview of Global Trends in MSC-Based Cell Therapy. Stem Cell Rev Rep. 2022; 18(5):1525-1545. PMC: 8958818. DOI: 10.1007/s12015-022-10369-1. View

Teoh P, Mohd Akhir H, Abdul Ajak W, Hiew V . Human Mesenchymal Stromal Cells Derived from Perinatal Tissues: Sources, Characteristics and Isolation Methods. Malays J Med Sci. 2023; 30(2):55-68. PMC: 10125235. DOI: 10.21315/mjms2023.30.2.5. View

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View

Guo J, Zhao Y, Fei C, Zhao S, Zheng Q, Su J . Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells. Cell Death Dis. 2018; 9(5):512. PMC: 5938708. DOI: 10.1038/s41419-018-0545-6. View

Pollalis D, Nair G, Leung J, Bloemhof C, Bailey J, Pennington B . Dynamics of microRNA secreted via extracellular vesicles during the maturation of embryonic stem cell-derived retinal pigment epithelium. J Extracell Biol. 2024; 3(9):e70001. PMC: 11393772. DOI: 10.1002/jex2.70001. View

Todo-Bom A, Mota-Pinto A, Alves V, Santos-Rosa M . Aging and asthma - changes in CD45RA, CD29 and CD95 T cells subsets. Allergol Immunopathol (Madr). 2011; 40(1):14-9. DOI: 10.1016/j.aller.2011.01.002. View

10.

Hu H, Wang D, Li L, Yin H, He G, Zhang Y . Role of microRNA-335 carried by bone marrow mesenchymal stem cells-derived extracellular vesicles in bone fracture recovery. Cell Death Dis. 2021; 12(2):156. PMC: 7862274. DOI: 10.1038/s41419-021-03430-3. View

11.

Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M . Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005; 23(8):1105-12. DOI: 10.1634/stemcells.2004-0330. View

12.

Hashimoto K, Inada M, Yamamoto Y, Ochiya T . Preliminary evaluation of miR-1307-3p in human serum for detection of 13 types of solid cancer using microRNA chip. Heliyon. 2021; 7(9):e07919. PMC: 8441074. DOI: 10.1016/j.heliyon.2021.e07919. View

13.

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

14.

Fafian-Labora J, Lesende-Rodriguez I, Fernandez-Pernas P, Sangiao-Alvarellos S, Monserrat L, Arntz O . Effect of age on pro-inflammatory miRNAs contained in mesenchymal stem cell-derived extracellular vesicles. Sci Rep. 2017; 7:43923. PMC: 5338265. DOI: 10.1038/srep43923. View

15.

Kmiotek-Wasylewska K, Bobis-Wozowicz S, Karnas E, Orpel M, Woznicka O, Madeja Z . Anti-inflammatory, Anti-fibrotic and Pro-cardiomyogenic Effects of Genetically Engineered Extracellular Vesicles Enriched in miR-1 and miR-199a on Human Cardiac Fibroblasts. Stem Cell Rev Rep. 2023; 19(8):2756-2773. PMC: 10661813. DOI: 10.1007/s12015-023-10621-2. View

16.

Pfeiffer V, Lingner J . Replication of telomeres and the regulation of telomerase. Cold Spring Harb Perspect Biol. 2013; 5(5):a010405. PMC: 3632062. DOI: 10.1101/cshperspect.a010405. View

17.

Berebichez-Fridman R, Montero-Olvera P . Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. Sultan Qaboos Univ Med J. 2019; 18(3):e264-e277. PMC: 6307657. DOI: 10.18295/squmj.2018.18.03.002. View

18.

Cen Y, Qi J, Chen L, Xia C, Zheng M, Liu Y . Decreased miR-17-92 cluster correlates with senescence features, disrupted oxidative homeostasis, and impaired therapeutic efficacy of mesenchymal stem cells. Am J Physiol Cell Physiol. 2023; 325(2):C443-C455. DOI: 10.1152/ajpcell.00515.2022. View

19.

Zhang W, Liu R, Zhang L, Wang C, Dong Z, Feng J . Downregulation of miR-335 exhibited an oncogenic effect via promoting KDM3A/YAP1 networks in clear cell renal cell carcinoma. Cancer Gene Ther. 2021; 29(5):573-584. PMC: 9113937. DOI: 10.1038/s41417-021-00335-3. View

20.

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View